Contact Us

Engineered Tissue Solutions Celebrates Publication of Second Randomized Controlled Trial Demonstrating Statistically Significant Outcomes with Mirragen® Bioactive Glass Matrix

Engineered Tissue Solutions and Transdiagen Partner to Pioneer Gene Expression Research in Chronic Wound Healing

New Whitepapter: Addressing the Burden of Complex Surgical Wounds with MirraSurg (WOUNDS)

ETS Awarded Technology Breakthrough Designation for Mirragen® Bioactive Glass with Premier, Inc.

ETS Named 2024 MedTech Outlook Wound Care Solution Company of the Year

Dr. Ralph Napolitano’s Work Using Bioactive Glass Technology Wins SAWC Fall 2024 People’s Choice Award

The People Have Spoken: Mercy’s Use of Bioactive Glass Technology Recognized at SAWC Fall 2024

Engineered Tissue Solutions Announces AJ Ford as New CEO

ETS Receives Innovative Technology Contract from Vizient for Mirragen® Advanced Wound Matrix

Celebrating International Women’s Day: Meet Daniella DeMichele, VP of Sales at Engineered Tissue Solutions (ETS)

Heraeus expands and diversifies its medical technology portfolio with acquisition of Mo-Sci Corporation and ETS Technology Holdings

Webinar: Second Landmark RCT Evaluating Mirragen in Diabetic Foot Ulcers | November 13, 2025

Join the leading minds in wound care for a webinar on a recently published RCT demonstrating Mirragen’s impact on non-healing DFUs.

WoundCon: A Case-Based Approach to Managing Complex Chronic Wounds with Borate-Based Bioactive Glass Fiber

Learn from the physicians who use bioactive glass technology.

Wound Masterclass: Destination Closure for Wounds

Gain CME Credits and Learn How Bioactive Glass Technology is Transforming Wound Care